Kersia is acquiring the animal biosecurity cleaners and disinfectants business from Neogen® through an exclusive agreement. This strategic transaction marks a major entry for the French group into the North American swine and poultry markets, complementing its existing domestic presence in the ruminant sector. The acquisition is a transformative step for the group, doubling its American activity and positioning it among the top three global players in the agricultural hygiene and disinfection market. The strategy focuses on leveraging the target's extensive product registration portfolio and its three dedicated U.S. manufacturing sites to provide nationwide coverage. This deal also expands the acquirer's international footprint into 20 new countries, particularly in Central America and the Asia-Pacific region, supporting its ambition to become the undisputed global leader in animal biosecurity.

The transaction values NEOGEN (ANIMAL BIOSECURITY DIVISION) at an EV/Revenue multiple of LOGIN.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.